Translumina strengthens technology portfolio with acquisition of Blue Medical Devices in Netherlands
Translumina strengthens technology portfolio with acquisition of Blue Medical Devices in Netherlands
Source: biospectrumindia.com
Eluting Balloons News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eluting Balloons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eluting Balloons Today - Breaking & Trending Today
Translumina acquires Blue Medical Devices, Netherlands
The acquisition shall also enable Translumina to use the patented Drug application technology of Blue Medical in other product lines in peripheral and neurovascular interventions complimenting its...
Source: medicaldialogues.in
Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices Netherlands
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Source: theweek.in
Global Drug Eluting Balloons (DEBs) Market 2021-2025 | COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats
/PRNewswire/ -- The drug eluting balloons (DEBs) market is expected to grow by USD 543.81 million, progressing at a CAGR of over 12% during the forecast period....
Source: prnewswire.com
Drug-Eluting Balloons (DEBs) Market to Record an Incremental Growth of USD 476.64 Million
Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- The drug-eluting balloons (DEBs) market is expected to grow by USD 476.64 million during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the drug-eluting balloons (DEBs) market in optimistic, probable, and pessimistic forecast scenarios. Enterprises will go through the Response, Recovery, and Renew phases. Technavio has announced its latest market research report titled Drug Eluting Balloons Market by Product and Geography - Forecast and Analysis ...
Source: prnewswire.com